The DOI matches its Crossref record.
Franco-Belgian Cooperative Study of Ursodeoxycholic Acid in the Medical Dissolution of Gallstones: A Double-Blind, Randomized, Dose-Response Study, and Comparison with Chenodeoxycholic Acid
Abstract
A double-blind randomized, multicenter study was carried out to determine the efficacy and safety of ursodeoxycholic acid (UDCA) at 4 doses of 2.1 to 16.2 mg-kg−1 day−1, and chenodeoxycholic acid (CDCA) at the dose of 16.9 mg-kg−1 -day−1, in 197 patients treated for up to 1 year for radiolucent gallstones in functioning (opacified) gallbladders. There was confirmed complete dissolution in 5.9% of patients receiving UDCA at the dose of 2.1 mg-kg−1 day−1, 18.9% in those receiving 4.2, 28.9% in those receiving 8.4, 14.6% in those receiving 16.2, and 20.0% in patients receiving CDCA. Partial (over 50%) or complete dissolution occurred in 29.4% of patients receiving 2.1 mg-kg−1−day−1 of UDCA, 37.8% of those receiving 4.2, 55.2% in those receiving 8.4, 48.7% in those receiving 16.2, and 50.0% in patients receiving CDCA. Complete dissolution occurred significantly more frequently in small (less than 5 mm in diameter) than in large (5 to 15 and more than 15 mm) stones. There was no significant influence of treatment on serum cholesterol and triglycerides in any of the groups. Serum aminotransferases remained normal (or lower than twice the upper normal limit) in all patients treated with UDCA. Diarrhea leading to cessation of treatment occurred in 5% of patients receiving UDCA, but was significantly less frequent than in those receiving CDCA. These results confirm that, within a 1-year period, UDCA is equally effective and induces diarrhea less frequently than CDCA, with an optimal dose (8 mg-kg−1−day−1) approximately twice lower than that of CDCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“UDCA has demonstrated promising results with a minimum dose of 500 mg/day, and even higher doses did not yield greater benefits (Table 2) [3940414243].”
From Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures (2022) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- Bachrach, 1982, Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis, Dig Dis Sci, 27, 737, 10.1007/BF01393771 · DOI
- Roda, 1982, Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study, Hepatology, 2, 804, 10.1002/hep.1840020611 · DOI
- Barbara, 1977, II trattamento medico della calcolosi biliare colesterolica nell' noma con acido chenodesossi-colico, Minerva Medica, 68, 3355
- Thistle, 1978, Chenotherapy for gallstone dissolution. I. Efficacy and safety, JAMA, 239, 1041, 10.1001/jama.1978.03280380041015 · DOI
- Bateson, 1978, Comparison of fixed doses of chenodeoxycholic acid for gallstone dissolution, Lancet, 1, 1111
- Nakagawa, 1977, Dissolution of cholesterol gallstones by ursodeoxycholic acid, Lancet, 2, 367, 10.1016/S0140-6736(77)90301-4 · DOI
- Zelen, 1974, The randomization and stratification of patients to clinical trials, J Chron Dis, 27, 367, 10.1016/0021-9681(74)90015-0 · DOI
- Armitage, 1955, Tests for linear trends in proportions and frequencies, Biometrics, 2, 375, 10.2307/3001775 · DOI
- Gross, 1975, Survival distribution: reliability, applications in the biomedical sciences, 23
- Peto, 1977, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br J Cancer, 35, 1, 10.1038/bjc.1977.1 · DOI · Paper page
- Salvioli, 1979, Ursodeoxycholic acid therapy for radiolucent gallstone dissolution, Curr Ther Res, 26, 995
- Allessandrini, 1980, A multicentre clinical trial on ursodeoxycholic acid: effect of different dosages upon cholesterol gallstone dissolution, Ital J Gastroenterol, 12, 185
- Tokyo Cooperative Gallstone Study Group, 1980, Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial, Gastroenterology, 78, 542, 10.1016/0016-5085(80)90870-7 · DOI · Paper page
- Tint, 1982, Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones, Ann Intern Med, 97, 351, 10.7326/0003-4819-97-3-351 · DOI · Paper page
- Maton, 1977, Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action, Lancet, 2, 1297, 10.1016/S0140-6736(77)90358-0 · DOI
- Okumura, 1977, Clinical studies on dissolution of gallstones using ursodeoxycholic acid, Gastroenterol Jpn, 12, 469, 10.1007/BF02781340 · DOI
- Meredith, 1982, Retrospective comparison of “cheno” and “urso” in the medical treatment of gallstones, Gut, 23, 382, 10.1136/gut.23.5.382 · DOI
- Sama, 1982, The effects of acute bile acid administration on biliary lipid secretion in healthy volunteers, Gastroenterology, 82, 515, 10.1016/S0016-5085(82)80401-0 · DOI
- Stiehl, 1978, Ursodeoxycholic acid versus chenodeoxycholic acid: comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gall-stones, Gastroenterology, 75, 1016, 10.1016/0016-5085(78)90068-9 · DOI
- Stiehl, 1980, Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid, Gastroenterology, 79, 1192, 10.1016/0016-5085(80)90912-9 · DOI
- Thistle, 1982, Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study, Dig Dis Sci, 27, 161, 10.1007/BF01311711 · DOI
- Schoenfield, 1981, Chenodiol {chenodeoxycholic acid) for dissolution of gallstones: the national cooperative gallstone study. A controlled trial of efficacy and safety, Ann Intern Med, 95, 257, 10.7326/0003-4819-95-3-257 · DOI
- Phillips, 1983, Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis: the national cooperative gallstone study, Hepatology, 3, 209, 10.1002/hep.1840030213 · DOI
- Leiss, 1982, Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones, Scand J Gastroenterol, 17, 587, 10.3109/00365528209181063 · DOI
- Bateson, 1981, Calcification of radiolucent gallstones during treatment with ursodeoxycholic acid, Br Med J, 283, 645, 10.1136/bmj.283.6292.645 · DOI
- Inter-Hospital Clinical Research Group, 1979, Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies, Curr Ther Res, 26, 230
- Frigerio, 1979, Ursodeoxycholic acid (UDCA) in the treatment of dyspepsia: report of a multicenter controlled trial, Curr Ther Res, 26, 214
- Del Vecchio Blanco, 1982, Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial, J Intern Med Res, 10, 278, 10.1177/030006058201000416 · DOI
Cited by
Sorted by citations
Son, S.-Y., Song, J. H., Shin, H.-J., Hur, H., & Han, S.-U. (2022) · Journal of Metabolic and Bariatric Surgery · doi:10.17476/jmbs.2022.11.2.30 · Cited by 23
Metadata
- Authors
- Erlinger, S., Le Go, A., Husson, J.-M., & Fevery, J.
- Venue
- Hepatology
- Published
- 1984-03
- Volume
- 4
- Issue
- 2
- Pages
- 308-314
- ISSN
- 0270-9139
- Cited by
- 100
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
